NCT06853522View on ClinicalTrials.gov

hucMSCs Exosomes for the Treatment of Active Ulcerative Colitis

EARLY_PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 30, 2025

Primary Completion Date

April 4, 2027

Study Completion Date

April 4, 2028

Conditions
Ulcerative Colitis (UC)
Interventions
DRUG

exosomes derived from human umbilical cord mesenchymal stem cells

The corresponding exosome content of 60×10\^6 umbilical cord mesenchymal stem cells was given

DRUG

saline +5% albumin

Equal amount of saline +5% albumin was given

Trial Locations (1)

200120

Shanghai East Hospital, Shanghai

All Listed Sponsors
lead

Shanghai East Hospital

OTHER